Position in ANAB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,778,355
+$455,747 QoQ
Shares Held
26,346
-26.4% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 23%
Shared 0%
None 77%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ANAB ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,778,355 | 26,346 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,322,608 | 23,848 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,213,551 | 25,032 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $895,449 | 29,244 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $681,651 | 30,705 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $574,485 | 30,903 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $398,220 | 30,077 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $970,359 | 28,966 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $744,659 | 29,715 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $657,357 | 29,190 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $629,598 | 29,393 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $542,408 | 30,201 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $618,173 | 30,392 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $728,395 | 33,474 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,026,729 | 33,131 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $832,443 | 32,632 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $621,117 | 30,597 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $635,866 | 25,702 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,054,212 | 30,337 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $831,146 | 30,647 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $782,750 | 30,187 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $796,037 | 36,939 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $841,164 | 39,124 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $528,593 | 35,837 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $930,592 | 41,656 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $479,360 | 33,925 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||